title: Role of human recombinant activated protein C and low dose corticosteroid therapy in sepsis.
abstract: Despite advances in modern medicine, sepsis remains a complex syndrome that has been associated with significant morbidity and mortality. Multiple organ failure associated with sepsis leads to high mortality and morbidity. About 28 - 50% deaths have been reported in patients with sepsis. The number of sepsis patients is increasing, with considerable burden on healthcare facilities. Various factors leading to a rise in the incidence of sepsis are (1) Improvement of diagnostic procedures (2) Increase in the number of immunocompromised patients taking treatment for various autoimmune disease, carcinomas, organ transplantation (3) Advances in intensive procedures (4) Nosocomial infections (5) Extensive use of antibiotics. With the better understanding of sepsis various modalities to modify pathophysiological response of septic patients have developed. Activated protein C and low-dose corticosteroid therapy have been tried in patients, with variable results.
authors.affiliation: Department of Anaesthesia and Critical Care, ERA'S Lucknow Medical College, Lucknow, India.
authors.forename: Aparna
authors.initials: A
authors.lastname: Shukla
authors.forename: Shilpi
authors.initials: S
authors.lastname: Awasthi